Securities

PDF

Overview

Robinson Bradshaw attorneys have extensive experience in handling a full range of securities matters, including capital markets transactions and securities-related litigation for a diverse client base, from publicly traded Fortune 500 companies to startup and growth companies.

We have helped our clients raise billions of dollars in a wide array of public and private securities offerings, including registered investment grade debt offerings, Rule 144A and Regulation S exempt offerings, recapitalizations, PIPE transactions, IPOs and follow-on equity offerings, as well as Rule 506 offerings and other types of private placements.

We regularly advise boards of directors and their audit, compensation, governance and special committees, as well as institutional shareholders and other capital markets participants. We provide securities counsel in significant corporate transactions, such as mergers and acquisitions, tender and exchange offers, and contested transactions.

Public companies routinely call on us to advise them on such matters as disclosure obligations, periodic reporting and proxy matters, insider trading, corporate governance, executive compensation, Securities and Exchange Commission investigations and disciplinary actions, internal investigations, stock exchange regulation, and compliance with Sarbanes-Oxley and Dodd-Frank mandates.

We also regularly assist private entities of all sizes in identifying and navigating securities issues and risks in the context of both capital raising and transactions that implicate securities laws.

Honors & Awards

  • U.S. News – Best Lawyers, Best Law Firms, national Tier 2 for securities/capital markets law, 2016-17; national Tier 3 for securities/capital markets law, 2013-15, 2018-19; national Tier 3 for securities regulation, 2017-19; Charlotte Tier 1 for securities/capital markets law, 2011-19; Charlotte Tier 1 for securities regulation, 2013-19; Raleigh Tier 1 for securities/capital markets law, 2019

Experience

News & Events

News

Events

Insights

Main Menu